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Abstract
Background—Neonatal seizures are associated with adverse neurologic sequelae including 
epilepsy in childhood. Here, we aim to determine whether levels of cytokines in neonates with 
brain injury are associated with acute symptomatic seizures or remote epilepsy.
Methods—This is a cohort study of term newborns with encephalopathy at UCSF between 
10/1993 and 1/2000 who had dried blood spots. Maternal, perinatal/postnatal, neuroimaging, and 
epilepsy variables were abstracted by chart review. Logistic regression was used to compare levels 
of cytokines with acute seizures and the development of epilepsy.
Results—In a cohort of 26 newborns with neonatal encephalopathy at risk for hypoxic ischemic 
encephalopathy with blood spots for analysis, diffuse alterations in both pro- and anti-
inflammatory cytokine levels were observed between those with (11/28, 39%) and without acute 
symptomatic seizures. Seventeen of the 26 (63%) patients had more than two years of follow-up 
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and 4/17 (24%) developed epilepsy. Higher levels of pro-inflammatory cytokines IL-6 and TNF-α, 
within the IL-1β pathway were significantly associated with epilepsy.
Conclusions—Elevations in pro-inflammatory cytokines in the IL-1β pathway were associated 
with later onset of epilepsy. Larger cohort studies are needed to confirm the predictive value of 
these circulating biomarkers.
Introduction
Neonatal seizures are an indicator of neurologic dysfunction with an incidence of 2.8 to 
4.4/1000 live births. (1, 2) Neonates with seizures are at high risk for a range of adverse 
neurologic sequelae compared to those without seizures, with up to 25% developing remote 
epilepsy. (3, 4) Risk factors for epilepsy include severity of encephalopathy, severity and 
type of brain injury, abnormal EEG background, and seizure frequency. (3–5) Together these 
variables can identify a high-risk group with an approximately 50% chance of developing 
epilepsy. (3–5) Additional predictors of epilepsy, however are needed in order to improve 
stratification, to better inform families, and to guide therapeutic studies that can alter 
epilepsy outcomes. (6, 7)
Alterations in levels of inflammatory cytokines, in particular the IL-1β pathway may serve 
as biomarkers of neurologic disease. These molecules are secreted by activated neuroglia 
often within an hour of an inciting central nervous system insult, including status 
epilepticus, stroke, and infection. (8–10) IL-1β activates its endogenous receptor with 
resultant increases in neuronal excitability. (11–13) After an initial CNS insult, ongoing 
inflammation may alter neuronal plasticity with network reorganization through several 
transcriptionally regulated effects, with potential for aberrant and epileptogenic circuits. 
(14–18) Activation of the pathway enhances the permeability of an already dysfunctional 
blood-brain barrier, allowing for movement and detection of these proteins into the 
peripheral circulation, raising the possibility of their utility as a biomarker of disease. (19, 
20)
In this study, we aimed to determine if levels of cytokines in neonates with brain injury are 
associated with acute symptomatic seizures and the development of epilepsy in childhood. 
We hypothesize that changes in a diffuse set of neonatal cytokines will be associated with 
acute seizures, though only increases in cytokines within the pro-inflammatory IL-1β 
pathway will be associated with remote epilepsy.
Methods
Subjects
This is a nested cohort study within a longitudinal investigation of term and near-term 
newborns at risk of neonatal encephalopathy. (21, 22) As previously reported, newborns 
were recruited who were admitted to the Intensive Care Nursery at UCSF and a nearby 
county hospital between 10/1993 and 1/2000 and had any of the following: 1) umbilical 
artery pH < 7.1; 2) umbilical artery base deficit > 10; 3) Apgar score ≤ 5 at 5 min of life; or 
4) overt neonatal encephalopathy as assessed by a neonatologist. This cohort was assembled 
before the adoption of therapeutic hypothermia. Neonates were excluded if there was 
Numis et al. Page 2
Pediatr Res. Author manuscript; available in PMC 2019 December 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
evidence of major congenital malformations, congenital metabolic diseases, or perinatal or 
intrauterine infection. The original cohort enrolled 125 neonates, 62 of which had cytokine 
levels evaluated from dried blood spots. Here, we aimed to evaluate cytokine levels in term 
neonates with high risk of brain injury. We applied additional exclusion criteria to the study 
base, excluding neonates: < 37 weeks gestational age; without both clinical and physiologic 
evidence of hypoxic-ischemia (and therefore not meeting our institutional therapeutic 
hypothermia criteria) (23); deceased during the birth admission; and, dried blood spots 
collected < 24 or > 120 hours after birth to allow for evaluation of relevant cytokines at peak 
levels after an acute neurologic injury. (21, 24, 25) Epilepsy classification was restricted to 
those with at least two years of follow-up to allow for the development of epilepsy. (3, 4)
Measurements
Cytokines—Cytokine levels were previously evaluated, and levels reported in an 
investigation evaluating their association with Magnetic Resonance Spectroscopy (MRS) 
and development. (21) In brief, dried blood spots were obtained from heel-stick blood as 
apart of California’s newborn screening program. Dried blood spots were analyzed by 
recycling immunoaffinity chromatography. (26) Twenty-five microliter samples were 
injected into serially connected microcolumns, each containing a different immobilized 
capture antibody (IL-1, IL-6, IL-8, IL-9, IL-12, IL-13, and TNF-α). (22) Analytes were 
released by treatment with acidic buffer and measured by laser-induced fluorescence.
Clinical data—Trained research assistants prospectively abstracted demographics and birth 
delivery data. (21) Encephalopathy scores were determined by expert review. (21, 22) 
Magnetic resonance imaging (MRI) injury scores were determined by combining scores for 
abnormalities in the deep gray nuclei and white matter. (27) Two authors (ALN, HCG) 
reviewed charts for encephalopathy etiology, presence of clinical and/or electrographic 
neonatal acute symptomatic seizures and epilepsy as defined by the International League 
Against Epilepsy 2014 criteria. (28)
Data Analysis—Analyses were performed using Stata 15.1 software (Stata Corp, College 
Station, Texas). The chi-square test was used to compare categorical variables, the Whitney 
Rank Sum test was used to compare ordinal variables, and the t-test was used to compare 
continuous variables with acute seizures or epilepsy. For the analyses of cytokines, linear 
regression was used to compare levels with continuous variables, the Kruskal-Wallis test was 
used with ordinal variables, and t-tests or analysis of variance were used for comparisons 
categorical predictors and outcome variables. We performed validation using sensitivity 
analyses with nonparametric tests. The area under the receiver operator curve (AUC) for 
cytokine levels and epilepsy were estimated using non-parametric methods.
Rv3.2.0 (R Foundation for Statistical Computing, Vienna, Austria) was used for clustering 
methods, using the gplots package. For each patient, cytokine values were scaled by 
subtracting the mean cytokine value across all patients from each particular patient cytokine 
level. This value was then divided by the standard deviation of the particular cytokine. 
Hierarchical agglomerative clustering algorithms were used to evaluate clusters of patients 
within the plasma cytokine determinants. Data were standardized as Z-scores by subtracting 
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mean and divided by standard deviation for each cytokine. Pearson’s correlation similarity 
metric and Ward linkage function were used for hierarchical agglomerative cluster analysis. 
For each clustering algorithm, dendrograms, heatmaps and bubblemaps were created to 
visualize the clusters and scaled cytokine values. Dark blue colors on the heatmaps represent 
low cytokine values, white colors represent average values, and red represent high values. 
Larger bubbles on bubble maps correspond to higher cytokine values.
The protocol was approved by the Committee for Human Research at the University of 
California, San Francisco and voluntary informed consent was obtained from parents or 
legal guardians.
Results
Cohort characteristics
From a study base of 62 neonates with encephalopathy, we excluded seven (11%) neonates < 
37 weeks gestational age, ten (16%) infants without clinical and physiologic evidence of 
hypoxia-ischemia, two (3%) deceased during the birth admission, and 10 (16%) infants with 
dried blood spots collected < 24 or > 120 hours after birth. Seven (11%) of 62 infants had 
missing clinical details on birth history and follow-up, leaving 26 infants for evaluation for 
acute symptomatic seizures. Among these 26 infants, 22 (85%) had radiologic evidence 
consistent with hypoxia-ischemia, three (12%) had radiologic evidence of ischemic or 
hemorrhagic stroke, and one (4%) had laboratory confirmed meningitis.
Acute seizures
Fifteen (58%) of 26 neonates had acute symptomatic seizures. Seizure onset was within 48 
hours of life in all subjects. Five neonates had rare (< 7) seizures, two had frequent recurrent 
seizures (≥7), and two had status epilepticus. The remaining six had greater than one seizure, 
but the precise burden could not be determined by chart review. Neonates with acute seizures 
had higher encephalopathy scores and a trend for higher MRI injury scores compared to 
those without acute seizures (Table 1). The groups did not differ on other demographic, 
clinical, and maternal risk factors.
Remote Epilepsy
Seventeen (65%) of 26 neonates had more than two years of follow-up data for review to 
evaluate for epilepsy onset after the neonatal period. Four of 17 (24%) developed epilepsy, 
all of whom had a history of acute symptomatic seizures. There were no significant 
differences in demographic, clinical, and maternal risk factors between those with and 
without remote epilepsy (Table 1).
Cytokine analyses
Cytokine levels were evaluated at 2.5 days of life (95% confidence interval: 2.1 to 2.9). 
There were no significant differences in timing of DBS collection between those with and 
without acute symptomatic seizure or between those with and without remote epilepsy. 
Cytokine levels did not vary by sex, race, gestational age, maternal age, encephalopathy 
etiology, encephalopathy score, or MRI severity score.
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Neonates with acute symptomatic seizures had broad difference in cytokines levels in 
comparison to those without acute seizures (Figure 1). Those with acute seizures had higher 
levels of IL-1, 6, 8, 9, 13, and TNF-α, as well as lower levels of IL-12 compared to those 
without acute seizures. In contrast, neonates who developed epilepsy had higher levels of 
cytokines specific to the IL-1β pathway, including IL-6 and TNF-α, as well as IL-9 (Figure 
2). There was trend for higher IL-1 levels (combined α- and β- subunits) in those who 
developed epilepsy (p=0.07).
We evaluated whether cytokine levels can discriminate between those with and without 
remote epilepsy with the receiver operator curve characteristics. The AUC for cytokines 
within the pro-inflammatory IL-1β pathway ranged from 0.87–0.88, demonstrating a strong 
effect and superior performance to IL-12 and IL-13 (Table 2). Hierarchical agglomerative 
clustering algorithms revealed difference in patterns of cytokine level changes in neonates 
with and without later onset of epilepsy (Figure 3). Dendrograms (Figure 3) and bubble/
heatmaps (Figure 4) confirmed correlations of cytokines within the pro-inflammatory IL-1β 
pathway (IL-1, IL-6, IL-8, TNF-α). IL-12 and IL-13, which are involved in disparate 
signaling pathways, were not correlated with the other cytokines measured.
Discussion
Here, we evaluated the association of inflammatory cytokines with acute symptomatic 
seizures and development of remote epilepsy in a cohort of neonates with encephalopathy. 
Acute symptomatic seizures in neonates with encephalopathy were associated with broad 
changes in cytokines in both pro- and anti-inflammatory cytokine levels. However, only 
increased levels of pro-inflammatory cytokines in the IL-1β pathway, and to a lesser extend 
IL-9 were associated with later development of epilepsy.
This group previously reported that in this cohort of neonates with encephalopathy, 
elevations in IL-1, IL-6, and IL-8 on dried blood spots were correlated with elevated lactate 
peaks on MRS. (21) Similarly, “The Extremely Low Gestational Age Newborn Study” 
(ELGAN) study evaluated several cytokines in premature infants born less than 28 weeks 
gestation using analyses of dried blood spots. (25) Changes in cytokine levels in several pro- 
and anti-inflammatory pathways were associated with the presence of intraventricular 
hemorrhage and/or white matter injury. (29) As neonatal brain injury is a risk factor for the 
development of acute symptomatic seizures, (3, 4) it is not surprising that we found acute 
symptomatic seizures after neonatal brain injury were associated with alterations in a 
number of pro- and anti-inflammatory cytokine pathways. Our findings corroborate data 
from a cohort of 13 neonates with hypoxic-ischemic encephalopathy, where serum levels of 
IL-1 receptor antagonist (an inhibitor of the IL-1 pathway) were lower and levels of IL-8 
were higher among neonates with seizures compared to controls. (24) Though, in all clinical 
studies evaluating cytokines levels in neonates to date, the development of remote epilepsy 
was not assessed.
Our finding that neonatal elevations of cytokines within the IL-1β pathway are associated 
with the development of epilepsy in childhood is novel. This pathway, however has been 
associated with epilepsy in several other clinical populations including adults with traumatic 
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brain injury and post-traumatic epilepsy. (30, 31) Therefore, this pathway may serve as a 
marker of epilepsy across several types of brain injury with the potential for understanding 
mechanisms of epileptogenesis. (32) Cytokines in the IL-1β pathway modulate the 
excitatory NMDA receptor and the inhibitory GABA receptor on neurons and astrocytes, 
resulting in lower seizure thresholds, which can lead to a positive feedback loop with 
perpetuation of seizure activity and brain inflammation. (11–13, 33, 34) After an initial brain 
injury, this ongoing inflammation can alter neuronal plasticity with network reorganization 
through several transcriptionally regulated effects, with potential for aberrant and 
epileptogenic circuits. (14–18)
In addition to differences in the IL-1β pathway we also found that increased levels of IL-9 
were associated with later development of epilepsy. The role of IL-9 in neurologic injury is 
less understood, with an emerging role in encephalomyelitis and multiple sclerosis. (35) 
Further investigations are needed to validate this finding.
Limitations of our study include our small sample size, which did not allow us to evaluate 
for potential confounding by brain injury severity on cytokine levels and later development 
of epilepsy. The etiology of neonatal encephalopathy however, was similar to that observed 
in larger cohorts of term neonates. While the prevalence of acute symptomatic seizures in 
neonates with encephalopathy is higher than that of contemporary cohorts (58%), it is 
consistent with the prevalence of acute symptomatic seizures in neonates before therapeutic 
hypothermia was adopted. (36) In this cohort, the evaluation of acute symptomatic seizures 
was not standardized. During the time period in which the cohort was assembled, EEG was 
not consistently used to evaluate for subclinical seizures in the neonatal period. While this 
could result in misclassification of neonates without ‘acute symptomatic seizure’, this would 
reduce our ability to detect an association of cytokine levels with seizures. The prevalence of 
epilepsy (24%) in this cohort is similar to that observed in larger cohort studies. (37) Owing 
to the retrospective cohort design, several patients were lost to follow-up for evaluation of 
epilepsy. While this could introduce bias, we anticipate cases of epilepsy were unlikely to be 
misclassified owing to referral patterns within our catchment area.
Here, we used dried blood spots to measure cytokine levels. This sampling results in 
increased measurement variability compared to measurement of cytokine levels in serum or 
plasma likely owing to the use of capillary blood, sample spread and activity of leukocytes 
during sample storage without early centrifugation. (38, 39) We would anticipate the use of 
serum or plasma would decrease the spread of cytokine levels by group and therefore 
strengthen the observed associations. Here, measurement of IL-1 levels included both the 
IL-1α and β- subunits. The IL-1β subunit is responsible for inflammation after a neurologic 
injury, whereas the α-subunit is largely skin derived and would not be expected to change 
after brain injury. (40) Levels of IL-1α and IL-1β are similar in circulation; therefore 
inclusion of IL-1α in measurements would dilute the association of IL-1β with our 
outcomes. If subunit composition analysis of IL-1β were possible, we hypothesize that the 
trend for increased IL-1 levels associated with epilepsy would have a larger effect size and 
become statistically significant.
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Our findings support the utility of circulating cytokines as a predictor of epilepsy after 
neonatal brain injury. Larger, prospective studies in contemporary cohorts of neonates are 
necessary to validate these findings and evaluate for interactions between changes in 
cytokines levels the IL-1β pathway with clinical factors known to increase risk of remote 
epilepsy such as brain injury and acute seizure severity.
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Article Impact Answers
In a cohort study of term neonates with encephalopathy, we evaluated the association of 
seven cytokines with acute symptomatic seizures and development of remote epilepsy.
Acute symptomatic seizures were associated with diffuse alterations in both pro- and 
anti-inflammatory cytokine levels.
However, only increased levels of pro-inflammatory cytokines in the IL-1β pathway, and 
to a lesser extend IL-9 were associated with later development of epilepsy.
These findings support the utility of circulating cytokines as a predictor of epilepsy after 
neonatal brain injury.
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Figure 1: 
Neonatal cytokine levels in children with acute symptomatic/early seizures (n=151) 
compared to those without seizures (n=11). Levels are plotted from 0–200 pg/mL, except for 
IL-12 and IL-13, which are plotted from 0–60 pg/mL. * p < 0.05, ** p< 0.01.
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Figure 2: 
Neonatal cytokine levels in children with epilepsy (n=4) compared to those without epilepsy 
(n=13). Levels are plotted from 0–200 pg/mL, except for IL-12 and IL-13, which are plotted 
from 0–60 pg/mL. * p<0.05.
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Figure 3: 
Dendrogram and heatmap of neonatal cytokines levels in 26 neonates with neonatal 
encephalopathy using hierarchical agglomerative clustering. Children with epilepsy are 
denoted with “1” and children without epilepsy are denoted with “0”. Dark blue colors 
represent low cytokine values, white colors represent average values, and red represent high 
values.
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Figure 4: 
Correlations among cytokine levels in 26 neonates with neonatal encephalopathy. Larger 
bubbles and darker red coloring indicates a higher correlation coefficient whereas smaller 
bubbles and dark blue coloring indicate lower correlation coefficients.
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Table 1:
Clinical characteristics and MRI findings among a cohort of neonates with encephalopathy.
Acute Seizures 
(n=15)
No Acute 
Seizures (n=11)
p-value Epilepsy (n=4) No Epilepsy 
(n=13) p-value
Male, n (%) 10 (67) 7 (63) 0.87 2 (50) 9 (69) 0.48
Average GA (wk)a 39.4 (1.5) 40.1 (1.2) 0.21 39.9 (1.4) 39.1 (1.2) 0.33
Birth Weight (g) a 3337 (129) 3175 (151) 0.42 3375 (172) 3289 (120) 0.73
Race, n (%)
 American Indian 1 (7) 0 1 (25) 0
 Asian/PI 2 (13) 3 (33) 0.23 1 (25) 3 (23) 0.28
 Black 4 (27) 0 1 (25) 3 (23)
 White 8 (53) 6 (67) 1 (25) 7 (54)
Hispanic, n (%) 0 2 0.09 0 0 -
Encephalopathy
Etiology b
 HIE/NE 11 (73) 11 (100) 0.17 3 (75%) 11 (84%) 0.14
 Stroke 3 (20) 0 0 2 (16%)
 Meningitis 1 (7) 0 1 (25%) 0
Encephalopathy Scorea (21, 22) 5 (4–6) 3 (2–4) <0.001 6 (4–6) 4 (4–6) 0.13
MRI Injury Score c (27) 5 (2–9) 2 (0–6) 0.07 6 (5–8) 3 (2–6) 0.15
Acute Seizures Not applicable 4 (100%) 8 (62%) 0.26
Maternal Risk Factors
 Age (years) a 30.5 (8.4) 30.7 (6.1) 0.97 25.4 (6.4) 30.8 (6.6) 0.17
 Steroid treatment, n (%) 1 (7) 0 0.38 0 1 (8) 0.57
 Antibiotic, n (%) 5 (33) 4 (36) 0.87 3 (75) 3 (23) 0.06
 Fever, n (%) 2 (13) 3 (27) 0.49 1 (25) 1 (8) 0.10
a
: mean (95% CI) or
b
median (interquartile range).
c
Radiologic evidence of HIE (including gray or white matter injury), radiologic evidence of ischemic or hemorrhagic stroke, and laboratory 
evidence of meningitis.
Abbreviations: GA: Gestational age; HIE/NE: Hypoxic-ischemic encephalopathy/ Neonatal encephalopathy; IQR: Interquartile Range; wk: week.
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Table 2:
Area under the receiver operating characteristic (AUC) coefficients for cytokine levels based upon 
development of remote epilepsy.
Receiver Operator Curve Area under the Curve (95% confidence interval)
IL-1 0.88 (0.72–1)
IL-6 0.85 (0.63–1)
IL-8 0.71 (0.45–0.97)
IL-9 0.88 (0.71–1)
IL-12 0.41 (0.15–0.68)
IL-13 0.53 (0.24–0.81)
TNF-α 0.87 (0.69–1)
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